JB

Jeffrey Bird

Managing Director at Bluebird Ventures

Palo Alto, California

Overview

Work Experience

BV

Bluebird Ventures

  • Managing Director

    2019 - Current

SH

Sutter Hill Ventures

  • Limited Partner

    2021

  • Managing Director

    2002

SH

Stanford Health Care

  • Board Member

    2022

LL

Leyden Labs

  • Investor

    2022

    Therapeutics company developing broad antiviral therapy for influenza, Coronavirus and other respiratory pathogens

Foresight Dx

  • Investor

    2020

    Diagnostic company developing tests for MRD in lymphoma and solid tumors. Series A with Stanford founders.

E

Epirium

  • Investor and Board Member

    2019

PI

Procyrion, Inc.

  • Investor and Board Member

    2019

GI

GRAIL, Inc.

  • Investor

    2016

Education

Investments

Procyrion

Series D

Total Funding: $78M

Forty Seven

Series A

Total Funding: $150M

Portola Pharmaceuticals

Series A

Total Funding: $200M

Relevant Websites